Fullgoal CSI Hugangshen Innovative Drugs Industry ETF

BlackRock Reduces Stake in WuXi Biologics

Stone Pharmaceutics Receives Clinical Trial Approval Notice for Daratumumab Injection

Shanghai Market Supervision Administration Enforcement Team Signs Compliance System Construction Cooperation Memorandum with Innovent Biologics

Sontek, China Pharmaceutical, and Huidai Acquisition-Z Disclose Latest Shareholder Rights

Chinese Innovative Pharmaceutical Companies Discuss Overseas Strategies: From 'Riding Others' Ships' to 'Building Their Own Ships'

Chairman Cai Dongchen of Stone Pharmaceutical Group Increased Shareholding to 25.26%

Blackstone Increases Its H Shares Stake in Wuxi Biologics to 5.10%

Five Subsidiaries of Hengrui Medicine Receive Approval for Multiple Drug Clinical Trials

WuXi AppTec's Controlling Shareholder Sells 41.34 Million Shares for 3.8 Billion Yuan in 30 Days

China's Pharmaceutical Industry Transforms into a Global Innovation Hub

Jade Pharmaceutical's SYH2085 Approved for Clinical Trials in China

Hengrui Pharmaceutical's Subsidiary Obtains Clinical Trial Approval for Leuprorelin Acetate Microspheres Injection

Hengrui Medicine Subsidiary Receives Clinical Trial Approval Notice for SHR-2906 Injection

WuXi Biologics Receives CDP Climate Change and Water Security 'A' Rating

JPMorgan Sees Opportunities in China's Healthcare Sector, Recommends Biotech and CXO Stocks

Sukoddju Injection Phase III Clinical Trial Achieves Positive Results for Severe Plaque Psoriasis Treatment

WuXi Biologics Shareholders Reduce Holdings, Stake Drops to 16.97%

WuXi Lux Holding Subsidiary Acquires Fund Investment and Transfers Shares

JPMorgan Increases Its Stake in WuXi Biologics by 872,123 Shares

Morgan Stanley Downgrades JP Group’s Target Price and Adjusts Profit Projections

01072

02979

01093

01709

00293

03899

02546

00695

02579

03939

<p>DONGFANG ELEC(01072) rose 8.17%, with a trading turnover 699.2 Million HKD, and a year-to-date rose 180.2%. WANGUO GOLD GP(02979) rose 8.05%, with a trading turnover 12.8 Million HKD, and a year-to-date rose 207.1%. CSPC PHARMA(01093) rose 7.64%, with a trading turnover 2.8 Billion HKD, and a year-to-date rose 95.6%.</p>

Top Gainers & Losers

DONGFANG ELEC

WANGUO GOLD GP

CSPC PHARMA

DL HOLDINGS GP

CATHAY PAC AIR

CIMC ENRIC

ZHIHUI MINING

DONGWU CEMENT

CNGR

Top 10 HK Stock Gainers (12.23)

01787

01772

01818

06936

02050

01880

09660

01024

06613

<p>CSPC PHARMA(01093) rose 7.64%, with a trading turnover 2.8 Billion HKD, and a year-to-date rose 95.6%. SD GOLD(01787) rose 4.64%, with a trading turnover 586.1 Million HKD, and a year-to-date rose 210.2%. SANHUA(02050) fell 6.55%, with a trading turnover 2.0 Billion HKD, and a year-to-date rose 47.8%. CTG DUTY-FREE(01880) fell 4.4%, with a trading turnover 1.1 Billion HKD, and a year-to-date rose 51.4%.</p>

- The Hang Seng Index fell by 0.11% but has gained 28.5% year-to-date, while the Hang Seng Tech Index decreased by 0.69% with a year-to-date increase of 22.8%.  
- Sihuan Pharmaceutical (01093) rose 7.64% with a trading volume of HKD 2.76 billion, reflecting a 95.6% increase for the year, and Shandong Gold (01787) increased by 4.64% with a volume of HKD 590 million, showing a remarkable 210.2% year-to-date gain.  
- However, Sanhua Intelligent Control (02050) dropped 6.55% amidst a trading volume of HKD 2 billion, resulting in a 47.8% increase this year, while China National Pharmaceutical (01880) fell 4.4% with a trading volume of HKD 1.05 billion, still up 51.4% year-to-date.

Top 10 HK Stock Gainers (12.23)

Top 5 HK Stock Gainers/Losers (>100B) (12.23)